Bionano Genomics, Inc. (BNGO) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bionano Genomics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.057 Good day and welcome to the BioNano fourth quarter and full year 2025 00:00:05.057 -- 00:00:09.623 earnings conference call. Today's conference is being recorded. 00:00:09.623 -- 00:00:14.068 At this time, I would like to turn the conference over to Webb Campbell from Gilmanton 00:00:14.068 -- 00:00:17.190 Group. Please go ahead. 00:00:18.754 -- 00:00:21.357 Thank you, Carmen, and good afternoon, everyone. 00:00:21.357 -- 00:00:26.904 Welcome to BioNano's fourth quarter and full year 2025 financial results conference call. 00:00:26.904 -- 00:00:31.959 On the call today is Dr. Eric Homlin, CEO and Principal Financial Officer 00:00:31.959 -- 00:00:37.004 of BioNano, and Mark Adamczyk, BioNano's Vice President of Accounting and Principal 00:00:37.004 -- 00:00:42.089 Accounting Officer. After market closed today, BioNano issued a press release 00:00:42.089 -- 00:00:46.634 announcing its financial results for the fourth quarter and full year 2025. 00:00:46.634 -- 00:00:51.479 A copy of the press release can be found on the investor relations page of the company's 00:00:51.479 -- 00:00:53.479 websites. 00:00:53.721 -- 00:00:58.132 Certain statements made during this conference call may be forward-looking statements 00:00:58.132 -- 00:01:03.380 Actual results may differ materially from such statements due to several factors 00:01:03.380 -- 00:01:08.829 and risks, some of which are identified in BioNano's press release and BioNano's 00:01:08.829 -- 00:01:13.697 report filed with the SEC. These forward-looking statements are based on information 00:01:13.697 -- 00:01:18.261 available to BioNano today, March 23, 2026, 00:01:18.385 -- 00:01:24.625 and the company assumes no obligation to update statements as circumstances change. 00:01:24.625...